Afisensp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2012-03-07
Share capital
250,000.00 PLN
Registered address
ul. Juliusza Lea 114/421, 30-133 Kraków, Poland
Electronic delivery address
AE:PL-14271-57496-IFWCT-25

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 1302 days for 2022).

  • 2023not filed
  • 202209/05/2026
  • 202124/05/2023
  • 202001/09/2022
  • 201901/09/2022
  • 201810/07/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.

Division · Scientific research and development1,493 / 1,953
Top 76%
Voivodeship · Małopolskie38,855 / 46,035
Top 84%
Country · Poland420,129 / 495,860
Top 85%

Results vs industry

Revenue
This companyUSD 5.52kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD -5.53kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 11.05kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 30.81kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Jerzy Szczepan Superata – President of the Management Board

Manner of representation

If the management board is a multi-member management board, joint action by two members of the management board is required to represent the company.

Ownership

OwnerSharesShare valueStake
Agnieszka Klinkowska Janasage 56
500$13,506.2120%
Jerzy Szczepan Superataage 68
2,000$54,024.8580%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2012-03-15 to 2025-10-01.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
MedappS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
COS LabP.S.A.
IntelliseqS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Medtransfersp. z o.o.
Oncotherics PolandS.A.
Fusiomicasp. z o.o.
Ncage TherapeuticsS.A.

Change history

DateEvent
2025-04-01Business suspended
2025-03-21Address change
2023-06-26PKD change
2014-03-10Address change
2012-03-07Entered in the register

FAQ

Last updated: 2026-05-09